Literature DB >> 33988967

Glycosylation Regulates N-Terminal Proteolysis and Activity of the Chemokine CCL14.

Siyao Wang1, Simon R Foster2,3, Julie Sanchez2,3, Leo Corcilius1,4, Mark Larance5, Meritxell Canals6,7, Martin J Stone2, Richard J Payne1,4.   

Abstract

Chemokines are secreted proteins that regulate leukocyte migration during inflammatory responses by signaling through chemokine receptors. Full length CC chemokine ligand 14, CCL14(1-74), is a weak agonist for the chemokine receptor CCR1, but its activity is substantially enhanced upon proteolytic cleavage to CCL14(9-74). CCL14 is O-glycosylated at Ser7, adjacent to the site of proteolytic activation. To determine whether glycosylation regulates the activity of CCL14, we used native chemical ligation to prepare four homogeneously glycosylated variants of CCL14(1-74). Each protein was assembled from three synthetic peptide fragments in "one-pot" using two sequential ligation reactions. We show that while glycosylation of CCL14(1-74) did not affect CCR1 binding affinity or potency of activation, sialylated variants of CCL14(1-74) exhibited reduced activity after treatment with plasmin compared to nonsialylated forms. These data indicate that glycosylation may influence the biological activity of CCL14 by regulating its conversion from the full-length to the truncated, activated form.

Entities:  

Year:  2021        PMID: 33988967     DOI: 10.1021/acschembio.1c00006

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  2 in total

Review 1.  Automated Peptide Synthesizers and Glycoprotein Synthesis.

Authors:  Jiekang Tian; Yaohao Li; Bo Ma; Zhongping Tan; Shiying Shang
Journal:  Front Chem       Date:  2022-05-05       Impact factor: 5.545

2.  EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.

Authors:  Yang Shu; Lingling He; Meixin Gao; Fan Xiao; Junru Yang; Shiwei Wang; Herui Wei; Fuyang Zhang; Hongshan Wei
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.